The Effect of AI-assisted cEEG Diagnosis on the Administration of Antiseizure Medication in Neonatal Seizures
Neonatal Seizure
About this trial
This is an interventional other trial for Neonatal Seizure
Eligibility Criteria
Inclusion Criteria:
- Postnatal age < or = 28 days;
- cEEG monitoring at least 24hours monitoring;
- Suspected seizures;
- Abnormal movement;
- Brain infarction;
- Risk of Intracranial hemorrhage;
- Abnormality of brain MRI or ultrasound;
- Hypoxic-ischemic encephalopathy or suspected Hypoxic-ischemic encephalopathy;
- Central nervous system (CNS) or systemic infections;
- Suspected genetic diseases or Positive genetic diagnoses;
Exclusion Criteria:
- The neonates with head scalp defect, scalp hematoma, edema and other contraindications which are not suitable for cEEG monitoring during hospitalization.
Sites / Locations
- Henan Children's HospitalRecruiting
- Children Hospital of Fudan University
- Chengdu Women's and Children's Central HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
The neonates evaluated by the routine assessment protocol and AI-assisted cEEG Diagnostic tool
The neonates evaluated by the routine assessment protocol
This group will be monitored by cEEG with standard operating procedure. The cEEG recording will be evaluated by neonatologists with the routine assessment protocol and AI assisted cEEG diagnostic tool in real time during cEEG monitoring. Both real-time cEEG and amplitude-integrated EEG traces are displayed at the bedside for clinical review. This group will follow the standard clinical protocols of the recruiting hospitals for ASM administration after the neonatologists' review.
This group will be monitored by cEEG with standard operating procedure. The cEEG recording will be evaluated by neonatologists with the routine assessment protocol during cEEG monitoring. Both real-time cEEG and amplitude-integrated EEG traces are displayed at the bedside for clinical review. This group will follow the standard clinical protocols of the recruiting hospitals for ASM administration after the neonatologists' review.